Tenascin C (TNC) is an attractive ECM molecule for targeted delivery of therapeutics, being overexpressed in several tumor types (glioblastoma, epithelial carcinoma, lymphomas of B and T cell origin, etc.)and associated with tumor progression and metastasis [12, 13]. The gene discussed is TNC; the disease is lymphoma.